<SEC-DOCUMENT>0000902664-23-003397-index.html : 20230602
<SEC-HEADER>0000902664-23-003397.hdr.sgml : 20230602
<ACCEPTANCE-DATETIME>20230602165650
ACCESSION NUMBER:		0000902664-23-003397
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230602
DATE AS OF CHANGE:		20230602

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TScan Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001783328
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				825282075
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-92700
		FILM NUMBER:		23989844

	BUSINESS ADDRESS:	
		STREET 1:		880 WINTER STREET
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
		BUSINESS PHONE:		857-399-9500

	MAIL ADDRESS:	
		STREET 1:		880 WINTER STREET
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lynx1 Capital Management LP
		CENTRAL INDEX KEY:			0001910456
		IRS NUMBER:				851134656
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		151 CALLE DE SAN FRANCISCO
		STREET 2:		SUITE 200 PMB 1237
		CITY:			SAN JUAN
		STATE:			PR
		ZIP:			00901-1607
		BUSINESS PHONE:		703-963-7214

	MAIL ADDRESS:	
		STREET 1:		151 CALLE DE SAN FRANCISCO
		STREET 2:		SUITE 200 PMB 1237
		CITY:			SAN JUAN
		STATE:			PR
		ZIP:			00901-1607
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>p23-1699sc13g.htm
<DESCRIPTION>TSCAN THERAPEUTICS, INC..
<TEXT>
Document 1 - file: p23-1699sc13g.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>p23-1699exhibit_99.htm
<DESCRIPTION>JOINT FILING AGREEMENT
<TEXT>
Document 2 - file: p23-1699exhibit_99.htm

</DOCUMENT>
</SEC-DOCUMENT>